Revised SPC: Ajovy (fremanezumab) 225 mg Pre-filled Pen for Injection

SPC has been updated to include hypersensitivity reactions, including urticaria, pruritus, rash and swelling, as an uncommon adverse drug reaction; the warning on hypersensitivity reactions in section 4.4 has been amended accordingly.

Source:

electronic Medicines compendium